STUDY OF ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORHISMS IN GENES OF ANTIOXIDANT DEFENCE ENZYMES WITH RISK OF DEVELOPING PROSTATE CANCER IN SIBERIA
Abstract
The influence of polymorphic substitutions in antioxidant system genes (SNPsrs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1gene and rs4880 in the MnSOD gene) on the risk of prostate cancer development in men living in the Siberian region of Russia was studied. The relationship between the studied genotypes and clinical parameters (disease stage and PSA level) was analyzed. For this purpose, the incidence of the studied allelic variants was compared between 399 with prostate cancer patients and 344 men with no history of prostate cancer. Genotyping was performed using real-time PCR. No statistically significant association with the risk of developing prostate cancer was found in the studied SNPs (p>0,05). For the GSTP1SNPrs1695, the correlation with disease stage was obtained: The GG genotype occurred more frequently in patients with stage III-IV prostate cancer (OR [C.I.]=2,66 [1,15–6,18], p=0,02). Both studied SNPs of the GSTP1 gene were associated with the level of prostate-specific antigen (PSA) in blood: the GG rs1695 genotype and TT rs1138272 genotype were associated with higher PSA levels (p=1,5×10-3)
About the Authors
N. A. Oskina
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk
Russian Federation
Russian Federation
N. A. Ermolenko
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk
Russian Federation
Russian Federation
U. A. Boyarskikh
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk
Russian Federation
Russian Federation
A. F. Lazarev
Altai Branch of the N.N. Blokhin Russian Cancer Research Center RAMS, Barnaul
Russian Federation
Russian Federation
V. D. Petrova
Altai Branch of the N.N. Blokhin Russian Cancer Research Center RAMS, Barnaul
Russian Federation
Russian Federation
D. I. Ganov
Altai Branch of the N.N. Blokhin Russian Cancer Research Center RAMS, Barnaul
Russian Federation
Russian Federation
I. S. Kunin
Novosibirsk State Medical University, Novosibirsk
Russian Federation
Russian Federation
O. G. Tonacheva
A.I. Kryzhanovsk Territorial Cancer Center, Krasnoyarsk
Russian Federation
Russian Federation
G. I. Lifshits
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk
Russian Federation
Russian Federation
M. L. Filipenko
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk
Russian Federation
Russian Federation
References
1. Ермоленко Н.А., Боярских У.А., Сушко А.Г. и др. Исследование влияния однонуклеотидных замен в генах MnSOD, GPX1 и GSTP1 на риск развития семейного и спорадического рака молочной железы у жительниц Алтайского края Российской Федерации // Генетика. 2010. Т. 46, № 12. С. 1685–1691.
2. Кострыкина Н.А., Печковский Е.А., Боярских У.А. и др. Ассоциация полиморфного варианта гена MnSOD и рака молочной железы у жительниц Алтайского края // Бюллетень экспериментальной биологии и медицины. 2009. Т. 147, № 1.С. 90–94.
3. Маниатис Т.Ф.Э., Сэмбрук Дж. Методы генетической инженерии. Молекулярное клонирование. М.: Мир. 1984. 480 с.
4. Теврюкова Н.С., Богатырев В.Н., Очиргоряев А.Б. Диагностика рака предстательной железы // Сибирский онкологический журнал. 2009. № 2 (32). С. 49–54.
5. Ames B.N., Gold L.S., Willett W.C. The causes and prevention of cancer // Proc. Natl. Acad. Sci. USA. 1995. Vol. 92 (12). P. 5258–5265.
6. Baker A.M., Oberley L.W., Cohen M.B. Expression of antioxidant enzymes in human prostatic adenocarcinoma // Prostate. 1997. Vol. 32 (4). P. 229–233.
7. Choi J.Y., Neuhouser M.L., Barnett M. et al. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers // Cancer Epidemiol. Biomarkers Prev. 2007. Vol. 16 (6). P. 1115–1120.
8. Dreher D., Junod A.F. Role of oxygen free radicals in cancer development // Eur. J. Cancer. 1996. Vol. 32A (1). P. 30–38.
9. Emerit I. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis // Free Radic. Biol. Med. 1994. Vol. 16 (1). P. 99–109.
10. Fair W.R., Fleshner N.E., Heston W. Cancer of the prostate: a nutritional disease? // Urology. 1997. Vol. 50 (6). P. 840–848.
11. Feig D.I., Reid T.M., Loeb L.A. Reactive oxygen species in tumorigenesis // Cancer Res. 1994. Vol. 54. (7). Suppl. S. 1890–1894.
12. Fleshner N.E., Kucuk O. Antioxidant dietary supplements: Rationale and current status as chemopreventive agents for prostate cancer // Urology. 2001. Vol. 57 (4). Suppl. 1. P. 90–94.
13. Forsberg L., de Faire U., Morgenstern R. Oxidative stress, human genetic variation, and disease // Arch. Biochem. Biophys. 2001. Vol. 389 (1). P. 84–93.
14. Hainaut P., Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro // Cancer Res. 1993. Vol. 53 (19). P. 4469–4473.
15. Ishida K., Morino T., Takagi K. et al. Nucleotide sequence of a human gene for glutathione peroxidase // Nucleic Acids Res. 1987. Vol. 15 (23). P. 10051.
16. Khandrika L., Kumar B., Koul S. et al. Oxidative stress in prostate cancer // Cancer Lett. 2009. Vol. 282 (2). P. 125–136.
17. Kucukgergin C., Gokpinar M., Sanli O. et al. Association between genetic variants in glutathione peroxidase 1 (GPx1) gene, GPx activity and the risk of prostate cancer // Minerva Urol. Nefrol. 2011. Vol. 63 (3). P. 183–190.
18. Lee W.H., Morton R.A., Epstein J.I. et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis // Proc. Natl. Acad. Sci. USA. 1994. Vol. 91 (24). P. 11733–11737.
19. Lin X., Tascilar M., Lee W.H. et al. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells // Am. J. Pathol. 2001. Vol. 159 (5). P. 1815–1826.
20. Matsui A., Ikeda T., Enomoto K. et al. Increased formation of oxidative DNA damage, 8-hydroxy-2’-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes // Cancer Lett. 2000. Vol. 151 (1). P. 87–95.
21. Navone N.M., Troncoso P., Pisters L.L. et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma // J. Natl. Cancer Inst. 1993. Vol. 85 (20). P. 1657–1669.
22. Nelson W.G., De Marzo A.M., DeWeese T.L. et al. The role of inflammation in the pathogenesis of prostate cancer // J. Urol. 2004. Vol. 172 (5 Pt 2). S. 6–11.
23. Rose D.P., Boyar A.P., Wynder E.L. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption // Cancer. 1986. Vol. 58 (11). P. 2363–2371.
24. Rosenblum J.S., Gilula N.B., Lerner R.A. On signal sequence polymorphisms and diseases of distribution // Proc. Natl. Acad. Sci. USA. 1996. Vol. 93 (9). P. 4471–4473.
25. Sutton A., Khoury H., Prip-Buus C. et al. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria // Pharmacogenetics. 2003. Vol. 13 (3). P. 145–157.
26. Wang S., Wang F., Shi X. et al. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk – A meta-analysis // Eur. J. Cancer. 2009. Vol. 45 (16). P. 2874–2881.
27. Wei H. Activation of oncogenes and/or inactivation of antioncogenes by reactive oxygen species // Med. Hypotheses. 1992. Vol. 39 (3). P. 267–270.
28. Wigginton J.E., Cutler D.J., Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium // Am. J. Hum. Genet. 2005. Vol. 76 (5). P. 887–893.
29. Woodson K., Tangrea J.A., Lehman T.A. et al. Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland) // Cancer Causes Control. 2003. Vol. 14 (6). P. 513–518.
30. Yossepowitch O., Pinchuk I., Gur U. et al. Advanced but not localized prostate cancer is associated with increased oxidative stress // J. Urol. 2007. Vol. 178 (4 Pt 1). P. 1238–1243.
Review
For citations:
Oskina N.A., Ermolenko N.A., Boyarskikh U.A., Lazarev A.F., Petrova V.D., Ganov D.I., Kunin I.S., Tonacheva O.G., Lifshits G.I., Filipenko M.L. STUDY OF ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORHISMS IN GENES OF ANTIOXIDANT DEFENCE ENZYMES WITH RISK OF DEVELOPING PROSTATE CANCER IN SIBERIA. Siberian journal of oncology. 2013;(3):37-42. (In Russ.)
Views:
524
Email this article 
